Temozolomide Sun
Analogs of Temozolomide Sun
Find cheaper analogs and generic equivalents for Temozolomide Sun.
Active Ingredient: temozolomide
Product Overview
About Temozolomide Sun
Temozolomide Sun is a medicine that contains the active substance temozolomide. It is available as capsules (5, 20, 100, 140, 180 and 250 mg). Temozolomide Sun is a ‘generic medicine’. This means that Temozolomide Sun is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Temodal.
What it is used for
Temozolomide Sun is an anticancer medicine. It is used to treat malignant glioma (brain tumours) in the following groups of patients: adults with newly diagnosed glioblastoma multiforme (an aggressive type of brain tumour). Temozolomide Sun is used first with radiotherapy and then on its own; adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment. Temozolomide Sun is used on its own in these patients. The medicine can only be obtained with a prescription.
How it is used
Treatment with Temozolomide Sun should be prescribed by a doctor with experience in the treatment of brain tumours. The dose of Temozolomide Sun depends on body surface area (calculated using the patient’s height and weight) and ranges from 75 to 200 mg per square metre, once a day. The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Sun is being used alone or with other treatments, and how the patient responds to treatment. Temozolomide Sun should be taken without food. Patients may also need to take medicines to prevent vomiting before taking Temozolomide Sun. Temozolomide Sun should be used with caution in patients with severe liver problems or with kidney problems.
How it works
The active substance in Temozolomide Sun, temozolomide, belongs to a group of anticancer medicines called alkylating agents. In the body, temozolomide is converted to another compound called MTIC. MTIC binds to the DNA of cells while they are reproducing, which stops cell division. As a result, the cancer cells cannot divide, slowing down the growth of tumours.
Active substance: temozolomide
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
